Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · IEX Real-Time Price · USD
0.347
+0.023 (7.21%)
At close: Jul 2, 2024, 4:00 PM
0.348
+0.002 (0.43%)
After-hours: Jul 2, 2024, 7:57 PM EDT
Ginkgo Bioworks Holdings Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for DNA stock have an average target of 1.56, with a low estimate of 0.20 and a high estimate of 3.00. The average target predicts an increase of 350.22% from the current stock price of 0.35.
Analyst Consensus: Sell
Analyst Ratings
The average analyst rating for DNA stock from 6 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 2 | 2 |
| Total | 4 | 4 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Sell Maintains $0.5 → $0.2 | Strong Sell | Maintains | $0.5 → $0.2 | -42.28% | Jun 26, 2024 |
| BTIG | BTIG | Hold → Strong Sell Downgrades n/a | Hold → Strong Sell | Downgrades | n/a | n/a | May 15, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $2 → $1 | Hold | Maintains | $2 → $1 | +188.60% | May 15, 2024 |
| William Blair | William Blair | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | May 10, 2024 |
| TD Cowen | TD Cowen | Buy Maintains $7 → $3 | Buy | Maintains | $7 → $3 | +765.80% | Mar 1, 2024 |
Financial Forecast
Revenue This Year
182.45M
from 251.46M
Decreased by -27.44%
Revenue Next Year
223.88M
from 182.45M
Increased by 22.71%
EPS This Year
-0.29
from -0.46
EPS Next Year
-0.19
from -0.29
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 197.7M | 273.0M | 314.4M | 636.2M |
| Avg | 182.5M | 223.9M | 275.3M | 612.0M |
| Low | 170.2M | 176.4M | 240.8M | 593.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -21.4% | 49.6% | 40.4% | 131.1% |
| Avg | -27.4% | 22.7% | 23.0% | 122.3% |
| Low | -32.3% | -3.3% | 7.6% | 115.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -0.28 | -0.16 | -0.05 | -0.24 |
| Avg | -0.29 | -0.19 | -0.09 | -0.23 |
| Low | -0.29 | -0.23 | -0.12 | -0.23 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.